Literature DB >> 1904819

The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound.

O W Odom1, W D Picking, T Tsalkova, B Hardesty.   

Abstract

Erythromycin binds to the large subunit of Escherichia coli ribosomes at a specific site that is very close to the amino acid of aminoacyl-tRNA bound into the peptidyltransferase center, and to the site to which puromycin is bound, the P and A sites, respectively, of the classical two-site model of ribosome function. Both erythromycin and puromycin affect fluorescence from fluorescent derivatives of aminoacyl-tRNAs, while both puromycin and aminoacyl-tRNAs affect fluorescence of fluorescent derivatives of erythromycylamine. The results demonstrate unequivocally that erythromycin, deacylated tRNA, a peptidyl-tRNA analogue and puromycin can be bound simultaneously to the same ribosome. Nascent peptides of more than a few amino acids in length block binding of erythromycin to the ribosomes but, unlike most other peptides, long polyphenylalanine chains can be synthesized on ribosomes to which erythromycin is bound. It is suggested that this refractory synthesis in the presence of erythromycin reflects the atypical physical and structural properties of polyphenylalanine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904819     DOI: 10.1111/j.1432-1033.1991.tb16071.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Isolation of antibiotic resistance mutations in the rRNA by using an in vitro selection system.

Authors:  Luisa Cochella; Rachel Green
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-04       Impact factor: 11.205

2.  Sequence selectivity of macrolide-induced translational attenuation.

Authors:  Amber R Davis; David W Gohara; Mee-Ngan F Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-13       Impact factor: 11.205

Review 3.  Insights into erythromycin action from studies of its activity as inducer of resistance.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

4.  Ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus display multiple defects in ribosomal functions and sensitivity against erythromycin.

Authors:  Aikaterini Tsagkalia; Fotini Leontiadou; Maria A Xaplanteri; Georgios Papadopoulos; Dimitrios L Kalpaxis; Theodora Choli-Papadopoulou
Journal:  RNA       Date:  2005-11       Impact factor: 4.942

Review 5.  How Macrolide Antibiotics Work.

Authors:  Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Trends Biochem Sci       Date:  2018-07-24       Impact factor: 13.807

6.  Discovery and analysis of 4H-pyridopyrimidines, a class of selective bacterial protein synthesis inhibitors.

Authors:  Wendy Ribble; Walter E Hill; Urs A Ochsner; Thale C Jarvis; Joseph W Guiles; Nebojsa Janjic; James M Bullard
Journal:  Antimicrob Agents Chemother       Date:  2010-08-09       Impact factor: 5.191

7.  Recombineering reveals a diverse collection of ribosomal proteins L4 and L22 that confer resistance to macrolide antibiotics.

Authors:  Elie J Diner; Christopher S Hayes
Journal:  J Mol Biol       Date:  2009-01-03       Impact factor: 5.469

8.  Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity.

Authors:  Ekaterini C Kouvela; Dimitrios L Kalpaxis; Daniel N Wilson; George P Dinos
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191

9.  Targeting the A site RNA of the Escherichia coli ribosomal 30 S subunit by 2'-O-methyl oligoribonucleotides: a quantitative equilibrium dialysis binding assay and differential effects of aminoglycoside antibiotics.

Authors:  Arthur Abelian; Andrew P Walsh; Georg Lentzen; Fareed Aboul-Ela; Michael J Gait
Journal:  Biochem J       Date:  2004-10-15       Impact factor: 3.857

Review 10.  Context-Specific Action of Ribosomal Antibiotics.

Authors:  Nora Vázquez-Laslop; Alexander S Mankin
Journal:  Annu Rev Microbiol       Date:  2018-06-15       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.